AETHLON MEDICAL, INC. Convertible Debt
AETHLON MEDICAL, INC. (AEMD) had Convertible Debt of $0 as of 2021-03-31, per its 10-K filed 2021-06-24.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2021-06-24
- 2021-03-31: Convertible Debt $0.00.
- 2020-03-31: Convertible Debt $992.59K; Convertible Debt as first filed $0.00.
- 2019-06-30: Convertible Debt $892.59K.
- 2019-03-31: Convertible Debt $992.59K.
| Period end | Convertible Debt | Convertible Debt as first filed |
|---|---|---|
| 2021-03-31 | $0.00 10-K · filed 2021-06-24 | |
| 2020-03-31 | $992.59K 10-K · filed 2021-06-24 | $0.00 10-K · filed 2020-06-25 |
| 2019-06-30 | $892.59K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $992.59K 10-K · filed 2020-06-25 | |
| 2018-03-31 | $992.59K 10-K · filed 2019-07-01 | |
| 2017-12-31 | $992.59K 10-Q · filed 2018-02-01 | |
| 2017-09-30 | $992.59K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $1.29M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.29M 10-K · filed 2018-06-08 | |
| 2016-12-31 | $662.81K 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $662.81K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $692.81K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $527.78K 10-K · filed 2017-06-28 | |
| 2015-12-31 | $527.78K 10-Q · filed 2016-02-04 | |
| 2015-09-30 | $527.78K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $527.78K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $527.78K 10-Q · filed 2016-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |